Onex Agrees to Acquire Gluskin Sheff All amounts in U.S.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
20
Onex Agrees to Acquire Gluskin Sheff

All amounts in U.S. dollars unless otherwise stated

TORONTO, March 22, 2019 (GLOBE NEWSWIRE) -- Onex Corporation (“Onex”) (TSX: ONEX) and Gluskin Sheff + Associates Inc. (“Gluskin Sheff”) (TSX: GS) today announced they have entered into a definitive agreement under which Onex will acquire 100% of Gluskin Sheff for C$14.25 per share.  The purchase price represents a 28% premium to Gluskin Sheff’s closing share price on March 22, 2019, and a 37% premium to the 60-day volume weighted average price (VWAP).  The total cash consideration for 100% of Gluskin Sheff’s equity is approximately C$445 million.

This combination will bring together two of Canada’s most entrepreneurial and successful investment firms and broaden the product suite available to Gluskin Sheff’s clients.  Gluskin Sheff will continue to be led by its existing leadership team and operate under its brand.

Gerry Schwartz, Chairman and Chief Executive Officer of Onex, said, “Gluskin Sheff is one of the largest and most respected independent wealth management firms in Canada, serving high net worth families and institutional investors, with a strong long-term track-record of risk-adjusted investment returns and outstanding client service.  By combining Gluskin Sheff’s public securities investing platforms with Onex’ private equity and private debt platforms the clients of both firms will have greater investment options.”

Jeff Moody, President and Chief Executive Officer of Gluskin Sheff, stated, “Onex is the ideal partner for us and our clients.  We have a strong cultural fit and a like-minded approach to investing and risk management, which includes financial alignment between our teams and our investors.  This partnership will provide us with the resources to better serve all of our clients and expand our product offerings with alternative investment strategies.”

Nancy Lockhart, Chair of the Gluskin Sheff Board, added, “We are delighted Onex has recognized our highly valued client base, team and reputation in the market and believe the all-cash offer represents an attractive opportunity for our shareholders.”

The transaction is to be effected by way of a court-approved plan of arrangement and is expected to close in the first half of 2019, subject to receipt of Gluskin Sheff shareholder and court approvals, required regulatory approvals and customary closing conditions.

Recommendation of the Board

The Gluskin Sheff Board of Directors, after consultation with its financial and legal advisors, has unanimously approved the transaction and determined that it is in the best interests of Gluskin Sheff, and unanimously recommends that Gluskin Sheff shareholders vote in favour of the transaction.  Blair Franklin Capital Partners Inc. (unrelated to the Funds managed by Gluskin Sheff), acting as financial advisor to the Gluskin Sheff Board, has provided the Gluskin Sheff Board with its opinion (as it relates to those not rolling-over their shares as described below) that the consideration under the transaction is fair, from a financial point of view, to such Gluskin Sheff shareholders.  Each of the directors and executive officers of Gluskin Sheff have entered into voting support agreements pursuant to which each has committed to vote in favour of the transaction.

Additional Transaction Details

Certain members of senior management of Gluskin Sheff have agreed to roll-over a significant portion of their Gluskin Sheff shares into Onex subordinate voting shares.  The number of Gluskin Sheff shares expected to roll-over is approximately 7% of the Gluskin Sheff shares outstanding.

A special meeting of Gluskin Sheff shareholders to consider the proposed transaction is expected to be held on or before May 16, 2019.  The transaction requires the approval of at least 66⅔% of the votes cast in person or by proxy at the meeting as well as the approval of a “majority of the minority” of votes cast by shareholders other than the individuals rolling-over their shares. Until closing, Gluskin Sheff is entitled to pay its regular quarterly cash dividend consistent with its dividend policy and past practice in an amount not exceeding C$0.25 per share.

The definitive transaction agreement is subject to customary non-solicitation provisions, including Gluskin Sheff’s right to consider and accept superior proposals, subject to a right to match in favour of Onex.  A termination fee of C$13.3 million will be payable by Gluskin Sheff to Onex should the transaction not close in certain circumstances, including if the transaction is not completed as a result of a superior proposal.

Further information regarding the transaction will be included in Gluskin Sheff’s management information circular, which will be mailed to Gluskin Sheff shareholders in due course.  Copies of the transaction agreement and the management information circular will be available on the SEDAR website at www.sedar.com .

About Onex

Onex is one of the oldest and most successful private equity firms.  Through its Onex Partners and ONCAP private equity funds, Onex acquires and builds high-quality businesses in partnership with talented management teams.  At Onex Credit, Onex manages and invests in leveraged loans, collateralized loan obligations and other credit securities. Onex has $31 billion of assets under management, including $6.4 billion of Onex proprietary capital, in private equity and credit securities.  With offices in Toronto, New York, New Jersey and London, Onex and the team are collectively the largest investors across Onex’ platforms.

Onex’ businesses have assets of $51 billion, generate annual revenues of $32 billion and employ approximately 217,000 people worldwide.  Onex shares trade on the Toronto Stock Exchange under the stock symbol ONEX.  For more information on Onex, visit its website at www.onex.com .  Onex’ security filings can also be accessed at www.sedar.com .

About Gluskin Sheff

Gluskin Sheff is one of Canada’s pre-eminent wealth management firms.  Founded in 1984 and serving high net worth private clients and institutional investors, the company is dedicated to meeting clients’ needs by delivering strong risk-adjusted returns together with the highest level of personalized client service.  The company’s common shares are listed on the Toronto Stock Exchange under the symbol GS.  For more information about the company, please visit www.gluskinsheff.com .

Forward-Looking Statements

This news release contains forward-looking statements about the proposed acquisition by Onex of Gluskin Sheff.  Specific forward-looking statements include statements with respect to certain strategic benefits; the timing of the Gluskin Sheff shareholder meeting and publication of related materials; and the expected completion date of the proposed transaction.

There can be no assurance that the proposed transaction will occur or that the anticipated strategic benefits will be realized.  The proposed transaction is subject to shareholder and court approvals and the fulfillment of certain conditions, and there can be no assurance that any such approvals will be obtained and/or any such conditions will be met.

Readers are cautioned not to place undue reliance on these forward-looking statements, which are based on Onex and Gluskin Sheff management’s current expectations as of the date of this news release.  Onex and Gluskin Sheff disclaim any obligation to update any forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by law.

For further information:

 Onex  Emilie Blouin  Director, Investor Relations  Tel: +1 416.362.7711 Gluskin Sheff David R. Morris Chief Financial Officer and Secretary Tel: +1 416.681.6036

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 392

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 169

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 406

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 257

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 390

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 265

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 322

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 398

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 401

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading

Top 5 Most Recently Viewed Articles

The Rise of Mycoplasma Testing: Future Growth and Trends

Updated Category News Views 102

Insights into the Growth of the Mycoplasma Testing Market The mycoplasma testing market is expected to balloon to USD 2.49 billion in the next few years. This impressive growth stems largely from the increasing use of cell culture techniques within biopharmaceutical research and development. As researchers and companies adopt these advanced methods, the demand for...

Continue Reading
Investors Urged to Examine Claims Against Toronto-Dominion Bank

Updated Category News Views 65

Faruqi & Faruqi Investigates Toronto-Dominion Bank Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently investigating potential claims on behalf of investors who have suffered significant financial losses from their investments in The Toronto-Dominion Bank (NYSE: TD). The firm is reaching out to investors who experienced losses exceeding $100,000,...

Continue Reading
Heifer International Advocates for Farmer Support Amidst Crisis

Updated Category News Views 403

Heifer International Advocates for Farmer Support Amid Climate Crisis Heifer International is calling for urgent action to assist smallholder farmers affected by the extreme weather patterns brought on by climate change. The recent impact of Tropical Depression Sara highlights the vulnerability of agricultural communities across Central America, prompting the organization...

Continue Reading
Mitsubishi Tanabe Pharma Unveils RADICAVA ORS Insights at NASP

Updated Category News Views 135

Mitsubishi Tanabe Pharma America Unveils Data on RADICAVA ORS Mitsubishi Tanabe Pharma America, Inc. (MTPA) is thrilled to share vital information regarding their innovative product, RADICAVA ORS (edaravone), at an upcoming event designed for specialized pharmacy professionals. This presentation aims at enhancing the understanding of it’s application in managing...

Continue Reading
Warren Buffett's Coca-Cola Dividend Strategy: A Love Affair

Updated Category News Views 593

Warren Buffett's Love for Coca-Cola Warren Buffett, a legendary investor, is set to receive a staggering $776 million in dividends from Coca-Cola. This immense wealth from his investment in Coca-Cola illustrates the power of dividends in wealth accumulation. Buffett's investment journey with Coca-Cola has not only been fruitful financially but has also created a personal...

Continue Reading